In this month’s Awards shortlist, LMG Life Sciences listed founding partner Dr. Kirsten Grüneberg as a finalist in the “Patent Strategy Attorney of the Year” category for the DC Metro Area.

LMG Life Sciences annually selects only a handful of individuals from major geographic areas as finalists in each category. While the names on the lists often hail from large, long-established firms, Dr. Grüneberg’s appearance speaks to the outsize advancement of the specialist patent firm that she co-founded. Now more than three years since its inception, the firm has already counseled clients on such wide-ranging issues as Hatch-Waxman exclusivity, Patent Term Extension, Orange Book listings, Biologics Price Competition and Innovation Act strategy, and patent subject matter eligibility for diagnostics.

For more information, please see Dr. Grüneberg’s listing on the LMG Life Sciences website.

Launched in September 2017, Grüneberg and Myers PLLC is a 100 percent female- and minority-owned international patent firm. With a broad and sophisticated practice, the firm provides a full range of patent support services, including patent prosecution, counseling, post-grant representation, and M&A due diligence to meet the growing and diverse needs of U.S.-based, European, and Asian companies, entrepreneurs, and inventors.